As a result of a translocation t(17;19)(q22;p13), the created TCF3::HLF fusion gene is a very rare abnormality (<0.7% of pediatric ALL cases) and highly resistant to standard treatment [94]. Here, TCF3 is linked to acute lymphoblastic leukemia.